Article
Clinicopathological and immunohistochemical characterization of melanotic neuroectodermal tumour of infancy with special focus on BRAFV600E and β-catenin expression.
Oral surgery, oral medicine, oral pathology and oral radiology - 1 Nov 2026
N Sivakumar, Trimukhe Akshay, Jot Kiran, Kaur Sharanjeet, Surya Varun, Mishra Deepika, Nayyar Vivek
Abstract excerpt
BACKGROUND: Melanotic neuroectodermal tumour of infancy is primarily treated by complete surgical excision; however, recurrence rates range from 20% to 25%. Recurrent lesions often exhibit more aggressive behaviour, which complicates surgical management and may preclude radical resection, thereby necessitating the use of adjuvant therapies. The limited molecular characterization of MNTI has impeded the...
Read the complete abstract on PubMedTopics
- Humans
- beta Catenin
- Proto-Oncogene Proteins B-raf
- Neuroectodermal Tumor, Melanotic
- Immunohistochemistry
